Drug Shortage Report for OCTOSTIM LIQ INJ. 15MCG/ML

Last updated on 2021-09-17 History
Report ID 136022
Drug Identification Number 02024179
Brand name OCTOSTIM LIQ INJ. 15MCG/ML
Common or Proper name Desmopressin Acetate Injection
Company Name FERRING INC
Market Status MARKETED
Active Ingredient(s) DESMOPRESSIN ACETATE
Strength(s) 15MCG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size Cartons of 10 ampoules
ATC code H01BA
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-03-19
Actual start date 2021-03-19
Estimated end date 2021-10-01
Actual end date 2021-09-16
Shortage status Resolved
Updated date 2021-09-17
Company comments New supply of Octostim Injection has been released by Ferring Canada
Health Canada comments
Tier 3 Status No
Contact Address 200 YORKLAND BLVD
TORONTO, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2021-09-17 English Compare
v8 2021-09-16 French Compare
v7 2021-09-16 English Compare
v6 2021-07-08 French Compare
v5 2021-07-08 English Compare
v4 2021-03-20 English Compare
v3 2021-03-19 French Compare
v2 2021-03-19 English Compare
v1 2021-03-19 English Compare

Showing 1 to 9 of 9